Posttransplant risks of cyclosporine: Nephrotoxicity.
D001379:Azathioprine / Q000627:therapeutic use; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007165:Immunosuppression Therapy; D007674:Kidney Diseases / Q000139:chemically induced*; D016030:Kidney Transplantation; D011184:Postoperative Period; D012306:Risk
D003524:Cyclosporins; D001379:Azathioprine